These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17572081)

  • 21. Synthetic hammerhead ribozymes as tools in gene expression.
    Lyngstadaas SP
    Crit Rev Oral Biol Med; 2001; 12(6):469-78. PubMed ID: 11806517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folding of a universal ribozyme: the ribonuclease P RNA.
    Baird NJ; Fang XW; Srividya N; Pan T; Sosnick TR
    Q Rev Biophys; 2007 May; 40(2):113-61. PubMed ID: 17931443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel ribozymes: discovery, catalytic mechanisms, and the quest to understand biological function.
    Weinberg CE; Weinberg Z; Hammann C
    Nucleic Acids Res; 2019 Oct; 47(18):9480-9494. PubMed ID: 31504786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of ribozymes that catalyse multiple-turnover Diels-Alder cycloadditions by using in vitro compartmentalization.
    Agresti JJ; Kelly BT; Jäschke A; Griffiths AD
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16170-5. PubMed ID: 16260754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Separate metal requirements for loop interactions and catalysis in the extended hammerhead ribozyme.
    Kim NK; Murali A; DeRose VJ
    J Am Chem Soc; 2005 Oct; 127(41):14134-5. PubMed ID: 16218578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of crystal structure interactions and thermodynamics for stabilizing mutations in the Tetrahymena ribozyme.
    Guo F; Gooding AR; Cech TR
    RNA; 2006 Mar; 12(3):387-95. PubMed ID: 16431981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hairpin and hammerhead ribozymes: how different are they?
    Burke JM
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1115-8. PubMed ID: 12440985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential activity of trans-acting hammerhead ribozymes targeted to beta amyloid peptide precursor mRNA by altering the symmetry of helices I and III.
    Denman RB; Smedman M; Kung L
    Arch Biochem Biophys; 1995 Oct; 323(1):71-8. PubMed ID: 7487076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binary hammerhead ribozymes with high cleavage activity.
    Kuznetsova M; Novopashina D; Repkova M; Venyaminova A; Vlassov V
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):1037-42. PubMed ID: 15560099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological and functional aspects of catalytic RNAs.
    Castanotto D; Rossi JJ; Deshler JO
    Crit Rev Eukaryot Gene Expr; 1992; 2(4):331-57. PubMed ID: 1486242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA catalysis.
    Scott WG
    Curr Opin Struct Biol; 1998 Dec; 8(6):720-6. PubMed ID: 9914252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tolerance to exchanges of the Watson Crick base pair in the hammerhead ribozyme core is determined by surrounding elements.
    Przybilski R; Hammann C
    RNA; 2007 Oct; 13(10):1625-30. PubMed ID: 17666711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hammerhead ribozyme design and application.
    Amarzguioui M; Prydz H
    Cell Mol Life Sci; 1998 Nov; 54(11):1175-202. PubMed ID: 9849614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pH-dependent conformational change, rather than the chemical step, appears to be rate-limiting in the hammerhead ribozyme cleavage reaction.
    Murray JB; Dunham CM; Scott WG
    J Mol Biol; 2002 Jan; 315(2):121-30. PubMed ID: 11779233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase.
    Sioud M; Jespersen L
    J Mol Biol; 1996 Apr; 257(4):775-89. PubMed ID: 8636981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New theophylline-activated Diels-Alderase ribozymes by molecular engineering.
    Petermeier M; Jäschke A
    Org Biomol Chem; 2009 Jan; 7(2):288-92. PubMed ID: 19109673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells.
    Bai Y; Li H; Vu GP; Gong H; Umamoto S; Zhou T; Lu S; Liu F
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7269-74. PubMed ID: 20360564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-function relationships of hammerhead ribozymes: from understanding to applications.
    Sigurdsson ST; Eckstein F
    Trends Biotechnol; 1995 Aug; 13(8):286-9. PubMed ID: 7662303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro evolution suggests multiple origins for the hammerhead ribozyme.
    Salehi-Ashtiani K; Szostak JW
    Nature; 2001 Nov; 414(6859):82-4. PubMed ID: 11689947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of universal fluorinated nucleobases on the catalytic activity of ribozymes.
    Klöpffer AE; Engels JW
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1347-50. PubMed ID: 14565415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.